Indication and application of anticoagulation therapy in Kawasaki disease
Abstract：The abnormal coagulation function mediated by vasculitis associated with Kawasaki disease and abnormal hemodynamics in coronary artery lesions will increase the risk of thrombosis in coronary artery,so anticoagulation therapy in Kawasaki disease is very important.The indications is based on the risk stratification of coronary artery.All children with Kawasaki disease should accept antiplatelet therapy.Patients with risk level Ⅲ should accept more than two kinds of antiplatelet drugs,patients with risk level Ⅳ and above should take aspirin and warfarin together,and patients with thrombosis and myocardial infarction should be given thrombolysis therapy early.Anticoagulation treatment should last at least 3 months.If the coronary artery persists,long term anticoagulant therapy should be performed.
Keywords：Kawasaki diseaseanticoagulation therapychild
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 588-591 )